Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2008

Mar 28, 2008

29777_dirs_2008-03-28_f824a636-9d7d-45e5-891b-1b47ff8d3697.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-03-27

Reporting Person: Bohuon Olivier (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-03-27 Common shares without par value M 34023 $41.7836 Acquired 91653 Direct
2008-03-27 Common shares without par value F 26311 $54.03 Disposed 65342 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-03-27 Option (right to buy) $41.7836 M 34023 Disposed 2013-05-31 Common shares (34023) Direct
2008-03-27 Option (right to buy) $54.03 A 26311 Acquired 2013-05-31 Common shares (26311) Direct

Footnotes

F1: Employee stock option, including replacement option feature granted pursuant to Abbott Laboratories Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.